Cargando…
CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1
BACKGROUND: Cytidine nucleotide triphosphate synthase 1 (CTPS1) is a CTP synthase which play critical roles in DNA synthesis. However, its biological regulation and mechanism in triple-negative breast cancer (TNBC) has not been reported yet. METHODS: The expression of CTPS1 in TNBC tissues was deter...
Autores principales: | Lin, Yuxiang, Zhang, Jie, Li, Yan, Guo, Wenhui, Chen, Lili, Chen, Minyan, Chen, Xiaobin, Zhang, Wenzhe, Jin, Xuan, Jiang, Meichen, Xiao, Han, Wang, Chuan, Song, Chuangui, Fu, Fangmeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734240/ https://www.ncbi.nlm.nih.gov/pubmed/34991621 http://dx.doi.org/10.1186/s12967-021-03206-5 |
Ejemplares similares
-
YTHDF3 facilitates triple-negative breast cancer progression and metastasis by stabilizing ZEB1 mRNA in an m(6)A-dependent manner
por: Lin, Yuxiang, et al.
Publicado: (2022) -
Thrombospondin 2 is a Functional Predictive and Prognostic Biomarker for Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy
por: Lin, Yuxiang, et al.
Publicado: (2022) -
Differential roles of CTP synthetases CTPS1 and CTPS2 in cell proliferation
por: Minet, Norbert, et al.
Publicado: (2023) -
HER2 copy number quantification in primary tumor and cell-free DNA provides additional prognostic information in HER2 positive early breast cancer
por: Chen, Xiaobin, et al.
Publicado: (2022) -
Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor–Positive Human Epidermal Growth Factor Receptor-2–Negative Early Breast Cancer Without Chemotherapy
por: Fu, Fangmeng, et al.
Publicado: (2022)